Cellectar Biosciences Inc (CLRB)

1.24 +0.01  +0.81% NASDAQ Oct 19, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/13/2020 Earnings Cellectar Biosciences Inc Third Quarter Earnings Results for 2020
08/10/2020 Earnings Cellectar Biosciences Inc Second Quarter Earnings Results for 2020
05/07/2020 Earnings Cellectar Biosciences Inc First Quarter Earnings Results for 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.cellectar.com
  • Investor Relations URL: N/A
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Nov. 13, 2020
  • Last Earnings Release: Aug. 10, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Cellectar Biosciences Inc is a clinical stage biopharmaceutical company. It focusses on development of targeted phospholipid drug conjugates for the treatment and imaging of cancer. The company's pipeline consists of pre-clinical and clinical product candidates including radiotherapeutic and chemotherapeutic phospholipid drug conjugates. Its portfolio of products in development includes CLR 131, CTX Product Portfolio consisting of CTX CLR 1800-P, CTX CLR 1602-PTX and CTX CLR 1700, CLR 125, CLR 124, and CLR 1502.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.